POCIHealthcare · Medical Instruments & Supplies

POCI Stock Forecast: Precision Optics Corp., Inc. Price Predictions for 2026-2027

Last close, 18 Sept 2026

$4.46

+2.29% on the day

The 1 Wall Street analysts covering Precision Optics Corp., Inc. hold a median 12-month price target of $8 — +79.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 58 of 100 as at 19 Sept 2026 — in the upper half.

Market cap

$48.8M

Ticker Nerd rank

58 / 100

Median analyst target

$8.00

Analysts covering

Revenue$8.7M+108.0% y/y

Operating income−$64K

Net income−$108K

Free cash flow−$674K

Quarterly, 8 quarters to 31 Mar 2026 · latest quarter's figure shown

Total return, dividends reinvested

+2.3%

+2.8%

YTD

+6.4%

+0.5%

From 52W high

−25.2%

From 52W low

+14.4%

$3.90

$5.96

52-week range, adjusted closes · the dot is the last close

Ticker Nerd rank

POCI stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Precision Optics Corp., Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 19 Sept 2026

58 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Growth

Volatility

Size

Accruals

Revisions

Momentum

Quality

Value

Issuance

Growth (97): Sales and profits are climbing, and climbing faster than before.

Issuance (11): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

POCI stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on POCI, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says1 analysts

1 Buy0 Hold0 Sell

Low $8.00Median $8.00High $8.00

The green dot is the last close — the median target sits +79.4% from it.

Recent analyst actionsNewest first

Of the 19 most recent actions, 11 moved their price target up and 8 moved it down.

Date	Firm	Action	Rating	Target
11 Oct 2022	Stifel	Maintains	Hold	$94 → $93
20 July 2022	Stifel	Maintains	Hold	$88 → $79
9 June 2022	Morgan Stanley	Maintains	Underweight	$95 → $80
19 Oct 2020	Stifel	Maintains	Hold	$71 → $78
18 June 2020	Baird	Maintains	Neutral	$53 → $63
17 Apr 2020	Baird	Maintains	Neutral	$49 → $53
18 Oct 2019	Baird	Maintains	Neutral	$48 → $52
19 July 2019	Stifel	Maintains	Hold	$54 → $49
16 Apr 2019	Stifel	Maintains	Hold	$50 → $55
8 Oct 2018	Stifel	Maintains	Hold	$49 → $50
20 July 2018	Stifel	Maintains	Hold	$41 → $49
15 June 2018	Canaccord Genuity	Upgrade	Hold	$40 → $44
19 Apr 2018	Baird	Maintains	Neutral	$48 → $43
19 Apr 2018	Stifel	Maintains	Hold	$49 → $41
7 Feb 2018	Baird	Maintains	Neutral	$45 → $48
7 Feb 2018	Stifel	Maintains	Hold	$51 → $49
3 Feb 2016	Baird	Upgrade	Outperform	$59 → $63
21 July 2015	Baird	Downgrade	Neutral	$64 → $63
20 Apr 2012	Canaccord Genuity	Downgrade	Hold	$36 → $40

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. POCI appears on the weeks it earns a place.

Performance

POCI vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 18 Sept 2026, Precision Optics Corp., Inc. returned +0.5% against +16.3% for the S&P 500, dividends included.

POCI vs S&P 500, last 12 monthsTotal return, rebased to 100

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

POCI analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Precision Optics Corp., Inc. (POCI) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: 153.5×
Price / sales: 1.7×
Price / book: 2.4×
EV / EBITDA: −9.4×

Growth & margins

Revenue growth (YoY): 108.0%
Earnings growth (YoY): 108.0%
Gross margin: 23.6%
Operating margin: −0.7%
Net margin: −17.0%

Returns & dividend

Return on equity: −29.6%
Return on assets: −11.2%
Dividend yield: 63.1%

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Precision Optics Corp., Inc. (POCI) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

Precision Optics Corp., Inc. has a market value of $48.8M and an enterprise value of $42.4M.
Revenue in the twelve months to 31 Mar 2026: $28.9M. The latest quarter grew 108.0% year on year.
Net income over the same four quarters: −$4.9M, a −17.0% net margin.
Free cash flow in the twelve months to 31 Mar 2026: −$1.9M, after $393K of capital spending.
Shares outstanding: 10.9M.
Trailing P/E: 153.5×; forward P/E: −63.7× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 63.13%, paying out 0% of earnings.
Precision Optics Corp., Inc. employs 90 people — $322K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 31 Mar 2026 · market figures as at 20 Sept 2026

Data provided by Twelve Data

Peers

POCI vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Instruments & Supplies

Company	Market cap	TKN rank
POCIPrecision Optics Corp., Inc.	$48.8M	58
NEPHNephros, Inc.	$45.8M	93
MLSSMilestone Scientific, Inc.	$35.9M	85
HBIOHarvard Bioscience, Inc.	$35.6M	98
DXRDaxor Corp.	$66.8M	52
FEMYFemasys, Inc.	$21.7M	43
RVPRetractable Technologies, Inc.	$21.5M	60

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Precision Optics Corp., Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest POCI news & analysis

Precision Optics Announces Initial Engineering Order from New Satellite Optical Communications Customer

GlobeNewsWire · 17 Sept 2026positive

Precision Optics Corporation announced it received an initial $50,000 development order from a U.S. space technology company that is building a new satellite constellation, marking a new customer in the satellite optical communications space.

Why it matters — This order signals Precision Optics' entry into a new satellite optical communications customer relationship, expanding its opportunities beyond its established medical and defense/aerospace markets.

Precision Optics Announces Receipt of $1.3 Million Follow-On Production Orders from Large Defense Company

GlobeNewsWire · 10 Sept 2026positive

Precision Optics Corporation announced it received follow-on production orders totaling approximately $1.3 million from a large U.S. defense contractor. The orders relate to the company's advanced optical instruments for the defense/aerospace industry.

Why it matters — This new production order flow from a major defense contractor signals continued demand for Precision Optics' defense-related optical products.

Precision Optics Appoints Peter Thier as Senior Vice President of Sales and Marketing

GlobeNewsWire · 18 Aug 2026neutral

Precision Optics Corporation announced that Peter Thier has joined the company as Senior Vice President of Sales and Marketing. The appointment was disclosed via a press release from the company's Littleton, Massachusetts headquarters.

Why it matters — POCI watchers would care because the company is strengthening its sales and marketing leadership, which could influence its commercial efforts in the medical and defense/aerospace markets.

Precision Optics to Participate in the Lytham Partners 2026 Consumer & Technology Investor Summit on August 18, 2026

GlobeNewsWire · 17 Aug 2026neutral

Precision Optics Corporation, Inc. announced it will participate in a webcast presentation at the Lytham Partners 2026 Consumer & Technology Investor Summit, which will take place virtually on Tuesday, August 18, 2026.

Why it matters — POCI watchers would care because the company's participation in this investor summit could increase visibility and engagement with the investment community.

FAQ

Frequently asked questions about POCI stock

What is the POCI stock price forecast for 2026-2027?

The 1 Wall Street analysts covering Precision Optics Corp., Inc. have a median 12-month price target of $8, with estimates ranging from $8 to $8. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is POCI stock a buy right now?

Of the 1 analysts covering Precision Optics Corp., Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Precision Optics Corp., Inc. 58 out of 100 across roughly 4,600 US stocks as at 19 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank POCI?

As at 19 Sept 2026, Precision Optics Corp., Inc. ranks 58 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Growth (97 of 100).

Will POCI stock go up?

No one can know that. What the data says: the median 12-month target from 1 analysts implies +79.4% from the last close, and Ticker Nerd's factor model ranks Precision Optics Corp., Inc. 58 out of 100 as at 19 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the POCI stock forecast for 2030?

No analyst covering Precision Optics Corp., Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for POCI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $8 to $8 over the next 12 months.

How has POCI stock performed over the past year?

Precision Optics Corp., Inc. returned +0.5% over the 12 months to 18 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Precision Optics Corp., Inc. do?

Precision Optics Corporation, Inc. is a medical technology and optical systems company that designs, develops, manufactures, and sells specialized imaging and illumination products.

What is the latest news on POCI?

The most recent item we track (GlobeNewsWire, 17 Sept 2026): "Precision Optics Announces Initial Engineering Order from New Satellite Optical Communications Customer". Precision Optics Corporation announced it received an initial $50,000 development order from a U.S. space technology company that is building a new satellite constellation, marking a new customer in the satellite optical communications space.

Company

About Precision Optics Corp., Inc.

Precision Optics Corporation, Inc. is a medical technology and optical systems company that designs, develops, manufactures, and sells specialized imaging and illumination products. Its portfolio includes endoscopes, endocouplers, microprecision lenses, micro medical cameras, and 3D endoscopes used in minimally invasive surgical procedures, along with custom optical devices tailored to customer requirements. The company also produces components and assemblies for industrial and military applications, giving it exposure to healthcare, defense, and advanced optics markets. Precision Optics Corporation serves medical device companies, hospitals, physicians, and other industrial customers, with a focus on products that support precision imaging and specialized instrumentation. Based in Gardner, Massachusetts, the company operates as a vertically integrated optics provider with capabilities spanning product concept, development, and manufacturing.

CEO Dr. Joseph N. Forkey · 90 employees · United States · https://www.poci.com